Mesothelioma Treatment Making Progress in Australia

This helps to individualize treatment approaches. A patient who has a poor prognostic profile with that marker, we would like to be very careful making plans for radical or chemotherapy treatment. For those patients with a better prognosis we would like to reserve more intense treatment for them.”

Additional research is currently underway at ADRI with the hope of identifying biomarkers that do not just point to survival, but to a patient’s sensitivity to specific anti-cancer drugs and treatments. The overall purpose is to provide tailored treatments for each individual patient.

As the number of mesothelioma cases diagnosed each year is expected to peak within the next decade, findings such as the one from ADRI are very important to improving survival rates. There is no current cure for mesothelioma and patients normally only survive between four and 18 months after diagnosis.

Additional information about mesothelioma may be found through the Mesothelioma Center.